CVRx, Inc. (CVRX) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Minneapolis, MN, アメリカ. 現CEOは Kevin Hykes.
CVRX を有する IPO日 2021-06-30, 206 名の正社員, に上場 NASDAQ Global Select, 時価総額 $203.13M.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
